Modern T cell technologies for immunotherapy of solid tumors
According to the common concept of immune editing, the interaction of malignant tumor cells and immune system is a complex multifactorial process, which may result in both antitumor effector activity and development of suppressor mechanisms that promote tumor growth. Accumulation of scientific knowl...
Main Authors: | M. S. Kuznetsova, Hiroshi Shiku, A. V. Karaulov, S. V. Sennikov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
St. Petersburg branch of the Russian Association of Allergologists and Clinical Immunologists
2023-04-01
|
Series: | Медицинская иммунология |
Subjects: | |
Online Access: | https://www.mimmun.ru/mimmun/article/view/2444 |
Similar Items
-
Adoptive T cell therapy for solid tumors: current landscape and future challenges
by: Víctor Albarrán, et al.
Published: (2024-03-01) -
Associação Brasileira de Hematologia, Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells. Review article: Cell therapy in solid tumors
by: Mirella Nardo, et al.
Published: (2021-11-01) -
Role of Immunotherapy in Sarcomas
by: Shivani Dalal, et al.
Published: (2024-01-01) -
Assessing the Future of Solid Tumor Immunotherapy
by: Prajna Guha, et al.
Published: (2022-03-01) -
CAR and TCR form individual signaling synapses and do not cross-activate, however, can co-operate in T cell activation
by: Markus Barden, et al.
Published: (2023-02-01)